SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Keeps Amrize at Equal-Weight, Cuts Target to $39

Wells Fargo maintained its Equal-Weight rating on Amrize and lowered its price target to $39 from $40.

AMRZ

Related stories